HALOPERIDOL decanoate injectable

Select language:
On this page

     

     
    Prescription under medical supervision

     

    Therapeutic action

    • Long-acting antipsychotic

    Indications

    • Chronic psychosis, maintenance therapy after stabilisation with oral haloperidol

    Forms and strengths, route of administration

    • 50 mg in 1 ml ampoule (50 mg/ml) for IM injection.
      DO NOT ADMINISTER BY IV INJECTION.

    Dosage and duration

    • Adult: one injection every 3 to 4 weeks

    The initial dose of haloperidol decanoate corresponds to approximately 10 times the daily dose of oral haloperidol.

     

    Daily dose
    oral haloperidol
    Monthly dose
    haloperidol decanoate IM
    50 mg solution
    haloperidol decanoate IM
    2.5 mg 25 mg ½ amp
    5 mg 50 mg 1 amp
    10 mg 100 mg 2 amp
    15 mg 150 mg 3 amp

     

    Contra-indications, adverse effects, precautions

    • Do not administer to patients with cardiac disorders (cardiac failure, recent myocardial infarction, conduction disorders, bradycardia, etc.), dementia (e.g. Alzheimer's disease), Parkinson's disease and history of neuroleptic malignant syndrome.
    • Administer with caution and carefully monitor use in elderly patients and patients with hypokalaemia, hypotension, hyperthyroidism, renal or hepatic impairment, history of seizures.
    • May cause: drowsiness, extrapyramidal syndrome, early or tardive dyskinesia, constipation, dry mouth, sexual dysfunction, QT-prolongation, ventricular arrhythmia, orthostatic hypotension.
    • In the event of extrapyramidal symptoms, combine with biperiden or trihexyphenidyl.
    • Avoid or monitor combination with: 
      • fluoxetine, paroxetine, sertraline, promethazine, ritonavir (increased plasma concentrations of haloperidol); 
      • carbamazepine, rifampicin, phenobarbital, phenytoin (decreased plasma concentrations of haloperidol);
      • drugs that prolong the QT interval (amiodarone, chloroquine, erythromycin, fluconazole, mefloquine, pentamidine, quinine, etc.).
    • Avoid alcohol during treatment.
    • Avoid in women of childbearing age or offer effective contraception.
    • Pregnancy and breastfeeding: avoid

    Remarks

    • Change buttock for each injection.

    Storage

     
    –  Below 25 °C